73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or
New treatment could increase lung cancer survival

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll

New treatment could increase lung cancer survival

byHudson Institute of Medical ResearchMYC-expression drives platinum resistance in vivo. A Schematic overview of experimental approach. B Representative CT images of RPM mice at time-points foll
Cancer hijacks the microbiome to glut itself on glucose

Cancer hijacks the microbiome to glut itself on glucose

by Garth Sundem,CU Anschutz Medical CampusHaobin Ye, PhD. Credit: CU Anschutz Medical CampusCancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact

Cancer hijacks the microbiome to glut itself on glucose

by Garth Sundem,CU Anschutz Medical CampusHaobin Ye, PhD. Credit: CU Anschutz Medical CampusCancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact
Renal impairment linked to worse prognosis in IgD multiple myeloma

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no
Novel mechanism supports antitumor response and T-cell survival

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe

Novel mechanism supports antitumor response and T-cell survival

by Melissa Rohman,Northwestern UniversityRepresentative composite image of a breast cancer specimen stained by multi-color IHC comprising CD8, Ki67, GCLC, GPX4, 923 A2AR, PanCK and DAPI. Represe
Using mice with humanized immune systems to test cancer immunotherapies

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di
Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers
Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat
Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr

Team identifies how certain immune cells contribute to worse survival rates in HER2-positive breast cancer patients

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with a type of breast cancer called HER2-positive are less likely to survive if their initial tr
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen
Examining the factors in air pollution that can lead to lung cancer

Examining the factors in air pollution that can lead to lung cancer

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA large international team of researchers has found that most lung cancers that result from exposure to air pollution are not due to indu

Examining the factors in air pollution that can lead to lung cancer

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA large international team of researchers has found that most lung cancers that result from exposure to air pollution are not due to indu
Extending chemo slashes risk of aggressive childhood leukemia coming back

Extending chemo slashes risk of aggressive childhood leukemia coming back

by Princess Máxima Center for Pediatric OncologyCredit: CC0 Public DomainMany children with acute lymphoblastic leukemia (ALL) have a good outcome of their disease. After two years of chemotherapy tre

Extending chemo slashes risk of aggressive childhood leukemia coming back

by Princess Máxima Center for Pediatric OncologyCredit: CC0 Public DomainMany children with acute lymphoblastic leukemia (ALL) have a good outcome of their disease. After two years of chemotherapy tre